Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)

SHA:600196 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	13,619	13,104	13,524	13,694	16,241	10,317
Trading Asset Securities	2,431	2,254	2,596	1,888	928.53	4,241
Cash & Short-Term Investments	16,049	15,358	16,120	15,582	17,170	14,558
Cash Growth	2.63%	-4.73%	3.45%	-9.25%	17.94%	22.01%
Accounts Receivable	10,094	9,955	8,765	8,457	8,172	6,474
Other Receivables	791.93	712.79	676.66	636.27	611.57	875.26
Receivables	10,886	10,668	9,442	9,093	8,783	7,538
Inventory	5,969	6,252	7,259	7,538	6,882	5,473
Other Current Assets	1,895	1,543	1,671	1,580	2,443	2,868
Total Current Assets	34,799	33,821	34,491	33,793	35,279	30,437
Property, Plant & Equipment	24,011	24,084	23,411	22,239	16,028	13,284
Long-Term Investments	29,363	27,269	25,865	25,012	25,549	23,920
Goodwill	10,709	10,810	10,905	10,852	10,337	9,400
Other Intangible Assets	14,426	13,999	14,468	13,482	12,471	10,276
Long-Term Accounts Receivable	256.62	213.33	198.83	83.01	91.66	77.4
Long-Term Deferred Tax Assets	948.69	985.34	757.78	624.47	442.57	265.59
Long-Term Deferred Charges	9,216	7,593	6,250	4,675	4,008	3,632
Other Long-Term Assets	1,698	1,280	1,114	2,512	2,836	2,014
Total Assets	125,428	120,054	117,461	113,470	107,164	93,306

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5,025	5,144	5,997	6,160	6,284	5,064
Accrued Expenses	5,536	5,649	5,408	5,414	5,577	4,807
Short-Term Debt	16,154	15,530	18,711	14,728	11,932	10,629
Current Portion of Long-Term Debt	6,704	5,635	3,983	4,422	5,230	4,986
Current Portion of Leases	360.91	348.4	340.98	329.53	184.41	141.5
Current Income Taxes Payable	256.67	253.91	278.7	250.63	619.34	474.22
Current Unearned Revenue	989.56	1,300	1,232	1,200	1,545	1,154
Other Current Liabilities	3,570	2,563	1,501	1,253	1,928	2,063
Total Current Liabilities	38,596	36,424	37,453	33,758	33,298	29,318
Long-Term Debt	13,017	11,862	10,444	13,505	12,100	9,049
Long-Term Leases	2,878	3,051	2,542	2,050	744.99	648.36
Long-Term Unearned Revenue	1,793	1,742	1,093	959.18	986.85	751.82
Long-Term Deferred Tax Liabilities	3,217	3,260	3,245	3,445	3,363	3,130
Other Long-Term Liabilities	2,525	1,874	2,751	3,137	2,562	2,029
Total Liabilities	62,026	58,214	57,527	56,853	53,055	44,927

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2,670	2,670	2,671	2,672	2,672	2,563
Additional Paid-In Capital	16,303	16,377	16,591	16,853	16,992	14,041
Retained Earnings	32,763	32,071	29,545	27,501	26,170	23,858
Treasury Stock	-607.96	-607.96	-234.38	-41.93	-53.25	-
Comprehensive Income & Other	-2,397	-1,769	-1,313	-1,300	-1,198	-1,266
Total Common Equity	48,731	48,742	47,261	45,685	44,582	39,196
Minority Interest	14,671	13,099	12,673	10,931	9,526	9,184
Shareholders' Equity	63,402	61,840	59,934	56,616	54,109	48,380
Total Liabilities & Equity	125,428	120,054	117,461	113,470	107,164	93,306

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	39,113	36,427	36,021	35,035	30,191	25,454
Net Cash (Debt)	-23,064	-21,069	-19,901	-19,453	-13,021	-10,896
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8.73	-7.96	-7.45	-7.29	-4.99	-4.25
Filing Date Shares Outstanding	2,640	2,640	2,657	2,672	2,672	2,563
Total Common Shares Outstanding	2,640	2,640	2,658	2,672	2,672	2,563
Working Capital	-3,797	-2,604	-2,962	34.99	1,981	1,118
Book Value Per Share	18.46	18.47	17.78	17.10	16.68	15.29
Tangible Book Value	23,596	23,933	21,888	21,351	21,774	19,519
Tangible Book Value Per Share	8.94	9.07	8.23	7.99	8.15	7.62
Land	997.46	1,021	943.68	951.74	201.31	203.68
Buildings	14,726	14,061	12,927	11,471	7,733	6,605
Machinery	16,437	16,347	15,392	14,026	10,700	9,197
Construction In Progress	2,973	3,055	3,435	4,938	4,897	3,618

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 31, 2026

Data Sources Report a data error